Jeanine R Jarnes – Projects and Grants — Experts@Minnesota

View Scopus Profile

Research activity per year

1 Not started
2 Active
3 Finished

6 results

Active
Long-Term Follow-up of Fabry Disease Subjects who have Undergone IV Infusion with ST-920, an rAAV2/6 Human Alpha Galactosidase A Gene Therapy
Whitley, C. B., Diethelm-Okita, B. M., Jarnes, J. R. & Miller, B. S.
SANGAMO THERAPEUTICS, INC.
12/4/23 → 11/30/30
Project: Research project
An Open-label, Phase 1/2 Study to Evaluate the Safety and Efficacy of Single-dose PR001A in Infants with Type 2 Gaucher Disease
Whitley, C. B., Eisengart, J., Jarnes, J. R. & Miller, B. S.
PREVAIL THERAPEUTICS INC
9/8/20 → 1/1/26
Project: Research project
Not started
Advanced Therapies Rare Genetic Disease Fellowship
Jarnes, J. R. & Whitley, C. B.
SANOFI-AVENTIS US
7/1/24 → 6/30/25
Project: Research project
Finished

WORLDFair Educational Meeting
Jarnes, J. R.
HORIZON PHARMA
10/21/23 → 11/30/23
Project: Research project
Phase 1/2, dose-escalation study to evaluate the safety, tolerability and efficacy of a single intravenous infusion of SPK-3006 in adults with late-onset Pompe disease
Whitley, C. B., Jarnes, J. R. & Karachunski, P. I.
SPARK THERAPEUTICS, INC
6/1/20 → 10/1/21
Project: Research project
Placebo Controlled Trial Evaluating Gabapentin for the T
Jarnes, J. R. & Hazaert, J.
GENZYME CORPORATION
2/23/12 → 12/31/14
Project: Research project

Your message has successfully been sent.

Your message was not sent due to an error.